RT Journal Article
SR Electronic
T1 Association of Visual Impairment with Risk for Future Parkinson’s Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.09.21249187
DO 10.1101/2021.01.09.21249187
A1 Zhu, Zhuoting
A1 Hu, Wenyi
A1 Liao, Huan
A1 Tan, Zachary
A1 Chen, Yifan
A1 Shi, Danli
A1 Shang, Xianwen
A1 Zhang, Xueli
A1 Huang, Yu
A1 Yu, Honghua
A1 Wang, Wei
A1 He, Mingguang
A1 Yang, Xiaohong
YR 2021
UL http://medrxiv.org/content/early/2021/01/11/2021.01.09.21249187.abstract
AB Background Although visual dysfunction is one of the most common non-motor symptoms among patients with Parkinson’s disease (PD), it is not known whether such dysfunction predates the onset of clinical PD.Objectives To examine the association of visual impairment (VI) with the future development of PD in the UK Biobank Study.Methods The UK Biobank Study is one of the largest prospective cohort studies of health, enrolling over 500,000 participants aged 40-69 years between 2006 and 2010 across the UK. VI was defined as a habitual distance visual acuity (VA) worse than 0.3 LogMAR in the better-seeing eye. Incident cases of PD were determined by self report data, hospital admission records or death records, whichever came first. Multivariable Cox proportional hazard regression models were used to investigate the association between VI and the risk of incident PD.Results A total of 117,050 participants were free of PD at the baseline assessment. During the median observation period of 5.96 (interquantile range [IQR]: 5.77-6.23) years, PD occurred in 222 (0.19%) participants. Visually impaired participants were at a higher risk of developing PD than non-VI participants (p<0.001). Compared with the non-VI group, the adjusted hazard ratio was 2.28 (95% CI 1.29-4.04, p=0.005) in the VI group. These results were consistent in the sensitivity analysis, where incident PD cases diagnosed within one year after the baseline assessment were excluded.Conclusions This prospective cohort study found that VI was associated with an increased risk of incident PD, suggesting that VI may represent a prodromal feature of PD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe present work was supported by the Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Project of Investigation on Health Status of Employees in Financial Industry in Guangzhou, China (Z012014075), Science and Technology Program of Guangzhou, China (202002020049). Prof. Mingguang He receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. The sponsor or funding organization had no role in the design or conduct of this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Access to the UK Biobank data was granted after registration. The application ID for the present study was 62443. The UK Biobank study has been approved by the North West Multi-center Research Ethics Committee. All participants provided informed consent prior to examinations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe UK Biobank is an open-access resource to researchers through registration of proposed research. This present study was approved and registered as study 62443 with the UK Biobank resource.PDParkinson’s diseaseVIvisual impairmentVAvisual acuityLogMARlogarithm of the minimum angle of resolutionNHSNational Health ServiceIQRinterquartile rangeHRhazard ratiosCIconfidence intervalsSDstandard deviationsPPVpositive predictive valueBMIbody mass index